Resistance, aspirin: See: Aspirin resistance.
The development of adverse cardiovascular events despite aspirin use has established an interest in a possible resistance to the drug. Several definitions have been set ...
Cyclooxygenase-1 [COX-1, prostaglandin synthase] catalyses the transformation of arachidonic acid to the unstable intermediate prostaglandin PGH 2.
May be a cause of recurrent ischaemic vascular events in patients taking aspirin. Aspirin reduces the odds of serious atherothrombotic vascular events and death in a broad ...
To the Editor: Aspirin resistance is a poorly defined term and could involve the clinical inability of aspirin to protect individuals from arterial ...
Cyclooxygenase-1 [COX-1, prostaglandin synthase] catalyses the transformation of arachidonic acid to the unstable intermediate prostaglandin PGH2. Subsequently ...